Report cover image

Global NAD+ Enhancer Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 198 Pages
SKU # APRC20282863

Description

Summary

According to APO Research, The global NAD+ Enhancer market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for NAD+ Enhancer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for NAD+ Enhancer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for NAD+ Enhancer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for NAD+ Enhancer is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of NAD+ Enhancer include EffePharm, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), GeneHarbor, NOMON Co., Ltd. (Teijin), Maac10 Formulas, Kingdomway, Herbalmax, Genex Formulas and EZZ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for NAD+ Enhancer, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of NAD+ Enhancer, also provides the sales of main regions and countries. Of the upcoming market potential for NAD+ Enhancer, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NAD+ Enhancer sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global NAD+ Enhancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for NAD+ Enhancer sales, projected growth trends, production technology, application and end-user industry.

NAD+ Enhancer Segment by Company

EffePharm
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
GeneHarbor
NOMON Co., Ltd. (Teijin)
Maac10 Formulas
Kingdomway
Herbalmax
Genex Formulas
EZZ
Elysium Health
Chromadex
CELFULL
Bontac
NAD+ Enhancer Segment by Type

Content <98%
Content ≥98%
NAD+ Enhancer Segment by Application

Health Care Products
ClinicsBeauty Products
Others
NAD+ Enhancer Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Enhancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ Enhancer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Enhancer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of NAD+ Enhancer in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NAD+ Enhancer sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 NAD+ Enhancer Market by Type
1.2.1 Global NAD+ Enhancer Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Content <98%
1.2.3 Content ≥98%
1.3 NAD+ Enhancer Market by Application
1.3.1 Global NAD+ Enhancer Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Health Care Products
1.3.3 ClinicsBeauty Products
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 NAD+ Enhancer Market Dynamics
2.1 NAD+ Enhancer Industry Trends
2.2 NAD+ Enhancer Industry Drivers
2.3 NAD+ Enhancer Industry Opportunities and Challenges
2.4 NAD+ Enhancer Industry Restraints
3 Global Market Growth Prospects
3.1 Global NAD+ Enhancer Revenue Estimates and Forecasts (2020-2031)
3.2 Global NAD+ Enhancer Revenue by Region
3.2.1 Global NAD+ Enhancer Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global NAD+ Enhancer Revenue by Region (2020-2025)
3.2.3 Global NAD+ Enhancer Revenue by Region (2026-2031)
3.2.4 Global NAD+ Enhancer Revenue Market Share by Region (2020-2031)
3.3 Global NAD+ Enhancer Sales Estimates and Forecasts 2020-2031
3.4 Global NAD+ Enhancer Sales by Region
3.4.1 Global NAD+ Enhancer Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global NAD+ Enhancer Sales by Region (2020-2025)
3.4.3 Global NAD+ Enhancer Sales by Region (2026-2031)
3.4.4 Global NAD+ Enhancer Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global NAD+ Enhancer Revenue by Manufacturers
4.1.1 Global NAD+ Enhancer Revenue by Manufacturers (2020-2025)
4.1.2 Global NAD+ Enhancer Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global NAD+ Enhancer Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global NAD+ Enhancer Sales by Manufacturers
4.2.1 Global NAD+ Enhancer Sales by Manufacturers (2020-2025)
4.2.2 Global NAD+ Enhancer Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global NAD+ Enhancer Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global NAD+ Enhancer Sales Price by Manufacturers (2020-2025)
4.4 Global NAD+ Enhancer Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global NAD+ Enhancer Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global NAD+ Enhancer Manufacturers, Product Type & Application
4.7 Global NAD+ Enhancer Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global NAD+ Enhancer Market CR5 and HHI
4.8.2 2024 NAD+ Enhancer Tier 1, Tier 2, and Tier 3
5 NAD+ Enhancer Market by Type
5.1 Global NAD+ Enhancer Revenue by Type
5.1.1 Global NAD+ Enhancer Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global NAD+ Enhancer Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global NAD+ Enhancer Revenue Market Share by Type (2020-2031)
5.2 Global NAD+ Enhancer Sales by Type
5.2.1 Global NAD+ Enhancer Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global NAD+ Enhancer Sales by Type (2020-2031) & (K Units)
5.2.3 Global NAD+ Enhancer Sales Market Share by Type (2020-2031)
5.3 Global NAD+ Enhancer Price by Type
6 NAD+ Enhancer Market by Application
6.1 Global NAD+ Enhancer Revenue by Application
6.1.1 Global NAD+ Enhancer Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global NAD+ Enhancer Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global NAD+ Enhancer Revenue Market Share by Application (2020-2031)
6.2 Global NAD+ Enhancer Sales by Application
6.2.1 Global NAD+ Enhancer Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global NAD+ Enhancer Sales by Application (2020-2031) & (K Units)
6.2.3 Global NAD+ Enhancer Sales Market Share by Application (2020-2031)
6.3 Global NAD+ Enhancer Price by Application
7 Company Profiles
7.1 EffePharm
7.1.1 EffePharm Comapny Information
7.1.2 EffePharm Business Overview
7.1.3 EffePharm NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 EffePharm NAD+ Enhancer Product Portfolio
7.1.5 EffePharm Recent Developments
7.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
7.2.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Comapny Information
7.2.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
7.2.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio
7.2.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
7.3 GeneHarbor
7.3.1 GeneHarbor Comapny Information
7.3.2 GeneHarbor Business Overview
7.3.3 GeneHarbor NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 GeneHarbor NAD+ Enhancer Product Portfolio
7.3.5 GeneHarbor Recent Developments
7.4 NOMON Co., Ltd. (Teijin)
7.4.1 NOMON Co., Ltd. (Teijin) Comapny Information
7.4.2 NOMON Co., Ltd. (Teijin) Business Overview
7.4.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio
7.4.5 NOMON Co., Ltd. (Teijin) Recent Developments
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Comapny Information
7.5.2 Maac10 Formulas Business Overview
7.5.3 Maac10 Formulas NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Maac10 Formulas NAD+ Enhancer Product Portfolio
7.5.5 Maac10 Formulas Recent Developments
7.6 Kingdomway
7.6.1 Kingdomway Comapny Information
7.6.2 Kingdomway Business Overview
7.6.3 Kingdomway NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Kingdomway NAD+ Enhancer Product Portfolio
7.6.5 Kingdomway Recent Developments
7.7 Herbalmax
7.7.1 Herbalmax Comapny Information
7.7.2 Herbalmax Business Overview
7.7.3 Herbalmax NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Herbalmax NAD+ Enhancer Product Portfolio
7.7.5 Herbalmax Recent Developments
7.8 Genex Formulas
7.8.1 Genex Formulas Comapny Information
7.8.2 Genex Formulas Business Overview
7.8.3 Genex Formulas NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Genex Formulas NAD+ Enhancer Product Portfolio
7.8.5 Genex Formulas Recent Developments
7.9 EZZ
7.9.1 EZZ Comapny Information
7.9.2 EZZ Business Overview
7.9.3 EZZ NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 EZZ NAD+ Enhancer Product Portfolio
7.9.5 EZZ Recent Developments
7.10 Elysium Health
7.10.1 Elysium Health Comapny Information
7.10.2 Elysium Health Business Overview
7.10.3 Elysium Health NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Elysium Health NAD+ Enhancer Product Portfolio
7.10.5 Elysium Health Recent Developments
7.11 Chromadex
7.11.1 Chromadex Comapny Information
7.11.2 Chromadex Business Overview
7.11.3 Chromadex NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Chromadex NAD+ Enhancer Product Portfolio
7.11.5 Chromadex Recent Developments
7.12 CELFULL
7.12.1 CELFULL Comapny Information
7.12.2 CELFULL Business Overview
7.12.3 CELFULL NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 CELFULL NAD+ Enhancer Product Portfolio
7.12.5 CELFULL Recent Developments
7.13 Bontac
7.13.1 Bontac Comapny Information
7.13.2 Bontac Business Overview
7.13.3 Bontac NAD+ Enhancer Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Bontac NAD+ Enhancer Product Portfolio
7.13.5 Bontac Recent Developments
8 North America
8.1 North America NAD+ Enhancer Market Size by Type
8.1.1 North America NAD+ Enhancer Revenue by Type (2020-2031)
8.1.2 North America NAD+ Enhancer Sales by Type (2020-2031)
8.1.3 North America NAD+ Enhancer Price by Type (2020-2031)
8.2 North America NAD+ Enhancer Market Size by Application
8.2.1 North America NAD+ Enhancer Revenue by Application (2020-2031)
8.2.2 North America NAD+ Enhancer Sales by Application (2020-2031)
8.2.3 North America NAD+ Enhancer Price by Application (2020-2031)
8.3 North America NAD+ Enhancer Market Size by Country
8.3.1 North America NAD+ Enhancer Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America NAD+ Enhancer Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America NAD+ Enhancer Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe NAD+ Enhancer Market Size by Type
9.1.1 Europe NAD+ Enhancer Revenue by Type (2020-2031)
9.1.2 Europe NAD+ Enhancer Sales by Type (2020-2031)
9.1.3 Europe NAD+ Enhancer Price by Type (2020-2031)
9.2 Europe NAD+ Enhancer Market Size by Application
9.2.1 Europe NAD+ Enhancer Revenue by Application (2020-2031)
9.2.2 Europe NAD+ Enhancer Sales by Application (2020-2031)
9.2.3 Europe NAD+ Enhancer Price by Application (2020-2031)
9.3 Europe NAD+ Enhancer Market Size by Country
9.3.1 Europe NAD+ Enhancer Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe NAD+ Enhancer Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe NAD+ Enhancer Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China NAD+ Enhancer Market Size by Type
10.1.1 China NAD+ Enhancer Revenue by Type (2020-2031)
10.1.2 China NAD+ Enhancer Sales by Type (2020-2031)
10.1.3 China NAD+ Enhancer Price by Type (2020-2031)
10.2 China NAD+ Enhancer Market Size by Application
10.2.1 China NAD+ Enhancer Revenue by Application (2020-2031)
10.2.2 China NAD+ Enhancer Sales by Application (2020-2031)
10.2.3 China NAD+ Enhancer Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia NAD+ Enhancer Market Size by Type
11.1.1 Asia NAD+ Enhancer Revenue by Type (2020-2031)
11.1.2 Asia NAD+ Enhancer Sales by Type (2020-2031)
11.1.3 Asia NAD+ Enhancer Price by Type (2020-2031)
11.2 Asia NAD+ Enhancer Market Size by Application
11.2.1 Asia NAD+ Enhancer Revenue by Application (2020-2031)
11.2.2 Asia NAD+ Enhancer Sales by Application (2020-2031)
11.2.3 Asia NAD+ Enhancer Price by Application (2020-2031)
11.3 Asia NAD+ Enhancer Market Size by Country
11.3.1 Asia NAD+ Enhancer Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia NAD+ Enhancer Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia NAD+ Enhancer Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA NAD+ Enhancer Market Size by Type
12.1.1 SAMEA NAD+ Enhancer Revenue by Type (2020-2031)
12.1.2 SAMEA NAD+ Enhancer Sales by Type (2020-2031)
12.1.3 SAMEA NAD+ Enhancer Price by Type (2020-2031)
12.2 SAMEA NAD+ Enhancer Market Size by Application
12.2.1 SAMEA NAD+ Enhancer Revenue by Application (2020-2031)
12.2.2 SAMEA NAD+ Enhancer Sales by Application (2020-2031)
12.2.3 SAMEA NAD+ Enhancer Price by Application (2020-2031)
12.3 SAMEA NAD+ Enhancer Market Size by Country
12.3.1 SAMEA NAD+ Enhancer Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA NAD+ Enhancer Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA NAD+ Enhancer Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 NAD+ Enhancer Value Chain Analysis
13.1.1 NAD+ Enhancer Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 NAD+ Enhancer Production Mode & Process
13.2 NAD+ Enhancer Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 NAD+ Enhancer Distributors
13.2.3 NAD+ Enhancer Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.